ImpediMed Ltd
ASX:IPD
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.044
0.155
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
ImpediMed Ltd
Research & Development
ImpediMed Ltd
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ImpediMed Ltd
ASX:IPD
|
Research & Development
-AU$221k
|
CAGR 3-Years
47%
|
CAGR 5-Years
40%
|
CAGR 10-Years
6%
|
|
R
|
Respiri Ltd
ASX:RSH
|
Research & Development
-AU$137.1k
|
CAGR 3-Years
54%
|
CAGR 5-Years
50%
|
CAGR 10-Years
28%
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Research & Development
-AU$815.8k
|
CAGR 3-Years
31%
|
CAGR 5-Years
27%
|
CAGR 10-Years
-39%
|
Cochlear Ltd
ASX:COH
|
Research & Development
-AU$277m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Research & Development
-AU$3.9m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
-12%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Research & Development
-AU$4.7m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
See Also
What is ImpediMed Ltd's Research & Development?
Research & Development
-221k
AUD
Based on the financial report for Jun 30, 2024, ImpediMed Ltd's Research & Development amounts to -221k AUD.
What is ImpediMed Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
6%
Over the last year, the Research & Development growth was 63%. The average annual Research & Development growth rates for ImpediMed Ltd have been 47% over the past three years , 40% over the past five years , and 6% over the past ten years .